🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for MASLD

Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD NCT06704321NA1 site📍 Québec Valbiotis · Tests: TOTUM-448, Placebo Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement NCT06814990NA1 site📍 Jena Stephanie Gräger · Tests: Cardiac MRI, Blood samples, Echocardiography Global Research Initiative for Patients Screening on MASH NCT05651724n/a13 sites📍 Brussels📍 Antwerp📍 Prague Julius Clinical NAFLD Clinical Care Pathway NCT06671886NA1 site📍 Houston VA Office of Research and Development · Tests: E-trigger Metabolic Features Effects on FAST Score in MASLD Patients NCT06867419n/a1 site📍 Tanta Tanta University · Tests: Transient Elastography A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH NCT06419374Phase 3330 sites📍 Birmingham📍 Homewood📍 Chandler Hoffmann-La Roche · Tests: Pegozafermin, Placebo Digoxin In NASH (CODIN) NCT06588699Phase 22 sites📍 New Haven📍 New Haven Yale University · Tests: Digoxin, Placebo Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease NCT07058155Phase 41 site📍 Cleveland The Cleveland Clinic · Tests: Transjugular Intrahepatic Portosystemic Shunt (TIPS), Sleeve Gastrectomy, Anti-Obesity Pharmacotherapy (Class Effect), … A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment NCT07807059Phase 11 site📍 Chengdu Fujian Shengdi Pharmaceutical Co., Ltd. · Tests: HRS-4729 Corazones Unidos Study NCT07298213NA1 site📍 Tucson University of Arizona · Tests: Your Heart, Your Health Spleen Stiffness Measurement for the Detection of Advanced Fibrosis NCT07440511n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS 4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis NCT07554183NA2 sites📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: 4D-Flow Liver and heart MRI with Gadolinium injection, Samples Without DNA Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease NCT06506513NA2 sites📍 Brussels📍 Louvain-la-Neuve Cliniques universitaires Saint-Luc- Université Catholique d… · Tests: High-intensity interval training, Moderate intensity exercise training, Low intensity exercise training A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD NCT07527910Phase 29 sites📍 Tucson📍 Coronado📍 Pasadena Regeneron Pharmaceuticals · Tests: ALN-PNP, Tirzepatide, Placebo Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease NCT07646197NA1 site📍 Detroit Henry Ford Health System · Tests: Peanut consumption Cardiovascular Risk Assessment and Coronary Calcium Score in Thai MASLD Patients NCT07865936n/a1 site📍 Bangkok Watcharasak Chotiyaputta Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective. NCT07652892n/a2 sites📍 Barcelona📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… Advanced Fibrosis Detection for MASLD in Primary Care NCT07159386NA1 site📍 Charleston Medical University of South Carolina · Tests: EHR alert Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH) NCT07013916NA2 sites📍 London📍 London Queen Mary University of London · Tests: fructose, glucose Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) NCT07481734Phase 21 site📍 Shenzhen Hudson Biotech · Tests: Tesamorelin, Placebo, Standardized lifestyle counseling Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians NCT07682363n/a1 site📍 Beijing Novo Nordisk A/S · Tests: No treatment is given A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) NCT06318169Phase 3370 sites📍 Birmingham📍 Chandler📍 Flagstaff Hoffmann-La Roche · Tests: Pegozafermin, Placebo Endohepatology-Based Reclassification of Treatment Indication in High-Risk MASLD NCT07877272n/a1 site📍 Münster University Hospital Muenster · Tests: Non-invasive MASLD and portal hypertension assessment, Single-session endohepatology assessment Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery NCT07326865NA1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: [6,6-D2]-labeled glucose (intravenous), Saline (0.9% sodium chloride infusion) Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease and Food Insecurity NCT07090083n/a1 site📍 San Francisco University of California, San Francisco Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease NCT06701968NA1 site📍 Uppsala Uppsala University · Tests: Healthy Nordic Diet, Usual Care Type 2 DIAbeTes With NAFLD: innOvative Biomarkers of Disease progressioN and clInical outComes NCT06567990NA4 sites📍 Dijon📍 Lyon📍 Nantes Hospices Civils de Lyon · Tests: Non-invasive test for the screening of MASLD-related advanced fibrosis in patients with T2D. Effect of Tirzepatide on Markers of MASLD in Patients With Obesity NCT06934642EARLY Phase 11 site📍 Albuquerque University of New Mexico · Tests: Tirzepatide Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo) NCT07330830n/a3 sites📍 Cayenne📍 Pointe-à-Pitre📍 Saint-Denis Centre Hospitalier Universitaire de la Guadeloupe Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial NCT07193927Phase 21 site📍 Girona AB Biotics, SA · Tests: Lactiplantibacillus plantarum Probiotic Mixture, Placebo comparator containing maltodextrin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy